125 related articles for article (PubMed ID: 28537669)
1. E2F2 induces MCM4, CCNE2 and WHSC1 upregulation in ovarian cancer and predicts poor overall survival.
Xie L; Li T; Yang LH
Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2150-2156. PubMed ID: 28537669
[TBL] [Abstract][Full Text] [Related]
2. DDA1 is induced by NR2F6 in ovarian cancer and predicts poor survival outcome.
Liu J; Li T; Liu XL
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1206-1213. PubMed ID: 28387912
[TBL] [Abstract][Full Text] [Related]
3. The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation.
Kojima M; Sone K; Oda K; Hamamoto R; Kaneko S; Oki S; Kukita A; Machino H; Honjoh H; Kawata Y; Kashiyama T; Asada K; Tanikawa M; Mori-Uchino M; Tsuruga T; Nagasaka K; Matsumoto Y; Wada-Hiraike O; Osuga Y; Fujii T
BMC Cancer; 2019 May; 19(1):455. PubMed ID: 31092221
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of Histone Methyltransferase WHSC1 Induces Apoptosis and Inhibits Cell Proliferation and Tumorigenesis in Salivary Adenoid Cystic Carcinoma.
Liu C; Jiang YH; Zhao ZL; Wu HW; Zhang L; Yang Z; Hoffman RM; Zheng JW
Anticancer Res; 2019 Jun; 39(6):2729-2737. PubMed ID: 31177108
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of KIF26B, Cell Migration and Proliferation of Human Ovarian Cancer Cell Lines In Vitro, and Patient Outcomes from Human Bioinformatic Analysis.
Yang X; Zhang L; Xie L
Med Sci Monit; 2018 Jun; 24():3863-3872. PubMed ID: 29880787
[TBL] [Abstract][Full Text] [Related]
6. WHSC1/NSD2 regulates immune infiltration in prostate cancer.
Want MY; Tsuji T; Singh PK; Thorne JL; Matsuzaki J; Karasik E; Gillard B; Cortes Gomez E; Koya RC; Lugade A; Odunsi K; Battaglia S
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589522
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic activation of WHSC1 functions as an oncogene and is associated with poor prognosis in cervical cancer.
Yin Z; Sun Y; Ge S; Sun J
Oncol Rep; 2017 Apr; 37(4):2286-2294. PubMed ID: 28260054
[TBL] [Abstract][Full Text] [Related]
8. MiR-2392 suppresses metastasis and epithelial-mesenchymal transition by targeting
Li J; Li T; Lu Y; Shen G; Guo H; Wu J; Lei C; Du F; Zhou F; Zhao X; Nie Y; Fan D
FASEB J; 2017 Sep; 31(9):3774-3786. PubMed ID: 28512191
[TBL] [Abstract][Full Text] [Related]
9. Expression of the E2F family of transcription factors and its clinical relevance in ovarian cancer.
Reimer D; Sadr S; Wiedemair A; Goebel G; Concin N; Hofstetter G; Marth C; Zeimet AG
Ann N Y Acad Sci; 2006 Dec; 1091():270-81. PubMed ID: 17341621
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of microRNA-154 targeting WHSC1 on cell proliferation of human skin squamous cell carcinoma through mediating the P53 signaling pathway.
Chen HQ; Gao D
Int J Biochem Cell Biol; 2018 Jul; 100():22-29. PubMed ID: 29727714
[TBL] [Abstract][Full Text] [Related]
11. E2F2 is upregulated by the ERK pathway and regulates decidualization via MCM4.
Zheng W; Zhao S; He H; Gu X; Long G; Chen X; Liang G; Li S
Gene; 2023 Jun; 871():147400. PubMed ID: 37028609
[TBL] [Abstract][Full Text] [Related]
12. Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2.
Wang H; Zhang X; Liu Y; Ni Z; Lin Y; Duan Z; Shi Y; Wang G; Li F
Oncotarget; 2016 Jun; 7(24):36577-36589. PubMed ID: 27174918
[TBL] [Abstract][Full Text] [Related]
13. Multiple myeloma driving factor WHSC1 is a transcription target of oncogene HMGA2 that facilitates colon cancer proliferation and metastasis.
Liu HH; Lee CH; Hsieh YC; Hsu DW; Cho EC
Biochem Biophys Res Commun; 2021 Aug; 567():183-189. PubMed ID: 34166916
[TBL] [Abstract][Full Text] [Related]
14. Integrin Subunit beta 8 (ITGB8) Upregulation Is an Independent Predictor of Unfavorable Survival of High-Grade Serous Ovarian Carcinoma Patients.
He J; Liu Y; Zhang L; Zhang H
Med Sci Monit; 2018 Dec; 24():8933-8940. PubMed ID: 30531684
[TBL] [Abstract][Full Text] [Related]
15. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic value of E2F activators in NSCLC and subtypes: a research based on bioinformatics analysis.
Gao Z; Shi R; Yuan K; Wang Y
Tumour Biol; 2016 Nov; 37(11):14979-14987. PubMed ID: 27655285
[TBL] [Abstract][Full Text] [Related]
17. The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients.
Gayarre J; Kamieniak MM; Cazorla-Jiménez A; Muñoz-Repeto I; Borrego S; García-Donas J; Hernando S; Robles-Díaz L; García-Bueno JM; Ramón Y Cajal T; Hernández-Agudo E; Heredia Soto V; Márquez-Rodas I; Echarri MJ; Lacambra-Calvet C; Sáez R; Cusidó M; Redondo A; Paz-Ares L; Hardisson D; Mendiola M; Palacios J; Benítez J; García MJ
J Gynecol Oncol; 2016 Jan; 27(1):e7. PubMed ID: 26463438
[TBL] [Abstract][Full Text] [Related]
18. Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells.
Iwasaki T; Tanaka K; Kawano M; Itonaga I; Tsumura H
Int J Oncol; 2015 Apr; 46(4):1543-50. PubMed ID: 25647078
[TBL] [Abstract][Full Text] [Related]
19. EMP3 is induced by TWIST1/2 and regulates epithelial-to-mesenchymal transition of gastric cancer cells.
Han M; Xu W
Tumour Biol; 2017 Jul; 39(7):1010428317718404. PubMed ID: 28718375
[TBL] [Abstract][Full Text] [Related]
20. In silico analyses identify gene-sets, associated with clinical outcome in ovarian cancer: role of mitotic kinases.
Ocaña A; Pérez-Peña J; Alcaraz-Sanabria A; Sánchez-Corrales V; Nieto-Jiménez C; Templeton AJ; Seruga B; Pandiella A; Amir E
Oncotarget; 2016 Apr; 7(16):22865-72. PubMed ID: 26992217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
